Lon Schneider, MD: New criteria to diagnose Alzheimer’s Disease
Lon Schneider, MD, Director of USC’s Alzheimer’s Center, discusses the new lexicon to discuss prodromal Alzheimer’s and the new biomarkers to diagnose AD decades sooner than current methods. These new methods promise to expedite clinical trials and drug development, but pose challenges for the current day clinician.
Alzheimer's Disease, Neurology, The Lancet, USC | apples49 | 
February 21, 2012 1:01 am
No Comments
No comments yet.
Notice: comments_rss_link is deprecated since version 2.5! Use post_comments_feed_link() instead. in /data/30/1/121/80/1121895/user/1185656/htdocs/wordpress/wp-includes/functions.php on line 3406
RSS feed for comments on this post.
TrackBack URI
